A. J. Brenner

407 total citations
10 papers, 288 citations indexed

About

A. J. Brenner is a scholar working on Radiology, Nuclear Medicine and Imaging, Genetics and Oncology. According to data from OpenAlex, A. J. Brenner has authored 10 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Radiology, Nuclear Medicine and Imaging, 3 papers in Genetics and 3 papers in Oncology. Recurrent topics in A. J. Brenner's work include Radiopharmaceutical Chemistry and Applications (4 papers), Glioma Diagnosis and Treatment (3 papers) and Cancer Research and Treatments (2 papers). A. J. Brenner is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (4 papers), Glioma Diagnosis and Treatment (3 papers) and Cancer Research and Treatments (2 papers). A. J. Brenner collaborates with scholars based in United States and Israel. A. J. Brenner's co-authors include David M. Goldenberg, Robert M. Sharkey, J. D. Burton, George Hajjar, Alexander Matthies, Abass Alavi, Jeffry A. Siegel, Michael G. Stabin, Arnold D. Rubin and Richard Sparks and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and Neuro-Oncology.

In The Last Decade

A. J. Brenner

10 papers receiving 281 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. J. Brenner United States	7	181	63	56	53	48	10	288
Masako Hosono Japan	10	116 0.6×	65 1.0×	53 0.9×	133 2.5×	37 0.8×	31	319
Tony S. Quang United States	6	140 0.8×	63 1.0×	32 0.6×	68 1.3×	71 1.5×	15	292
L. Mangel Hungary	10	77 0.4×	63 1.0×	95 1.7×	74 1.4×	26 0.5×	18	342
Paul Chinn United States	8	365 2.0×	140 2.2×	244 4.4×	89 1.7×	67 1.4×	11	532
Danny L. Costantini Canada	8	266 1.5×	152 2.4×	12 0.2×	63 1.2×	87 1.8×	12	367
Ly Tran Netherlands	8	181 1.0×	111 1.8×	33 0.6×	28 0.5×	47 1.0×	21	333
John Floyd United States	12	47 0.3×	74 1.2×	19 0.3×	76 1.4×	55 1.1×	39	307
Zi-Fen Su Canada	8	192 1.1×	104 1.7×	13 0.2×	88 1.7×	88 1.8×	15	349
Don K. Hamlin United States	8	322 1.8×	69 1.1×	122 2.2×	57 1.1×	65 1.4×	12	402
Kwang Il Kim South Korea	14	216 1.2×	155 2.5×	12 0.2×	95 1.8×	131 2.7×	28	444

Countries citing papers authored by A. J. Brenner

Since Specialization

Citations

This map shows the geographic impact of A. J. Brenner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. J. Brenner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. J. Brenner more than expected).

Fields of papers citing papers by A. J. Brenner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. J. Brenner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. J. Brenner. The network helps show where A. J. Brenner may publish in the future.

Co-authorship network of co-authors of A. J. Brenner

This figure shows the co-authorship network connecting the top 25 collaborators of A. J. Brenner. A scholar is included among the top collaborators of A. J. Brenner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. J. Brenner. A. J. Brenner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Brenner, A. J., Yoni Cohen, James J. Vredenburgh, et al.. (2015). 2901 Phase 2 study of VB-, an anti-cancer gene therapy, as monotherapy followed by combination of VB-111 with bevacizumab, in patients with recurrent glioblastoma. European Journal of Cancer. 51. S584–S584. 1 indexed citations

Brenner, A. J., Yoni Cohen, James J. Vredenburgh, et al.. (2014). NT-07 * PHASE 1-2 DOSE-ESCALATION STUDY OF VB-111, AN ANTI-ANGIOGENIC GENE THERAPY, AS MONOTHERAPY AND IN COMBINATION WITH BEVACIZUMAB, IN PATIENTS WITH RECURRENT GLIOBLASTOMA. Neuro-Oncology. 16(suppl 5). v160–v160. 2 indexed citations

Brenner, A. J., Jasgit C. Sachdev, Mitesh J. Borad, et al.. (2014). 4LBA A phase 1 study of first-in-class microRNA-34 mimic, MRX34, in patients with hepatocellular carcinoma or advanced cancer with liver metastasis. European Journal of Cancer. 50. 196–196. 5 indexed citations

Phillips, William T., Beth Goins, Ande Bao, et al.. (2012). Rhenium-186 liposomes as convection-enhanced nanoparticle brachytherapy for treatment of glioblastoma. Neuro-Oncology. 14(4). 416–425. 69 indexed citations

Sarantopoulos, John, N. Gabrail, Stacy L. Moulder, et al.. (2010). ANG1005: Results of a phase I study in patients with advanced solid tumors and brain metastases.. Journal of Clinical Oncology. 28(15_suppl). 2556–2556. 10 indexed citations

Drappatz, Jan, A. J. Brenner, S. Rosenfeld, et al.. (2010). ANG1005: Results of a phase I study in patients with recurrent malignant glioma.. Journal of Clinical Oncology. 28(15_suppl). 2009–2009. 12 indexed citations

Sharkey, Robert M., George Hajjar, A. J. Brenner, et al.. (2005). A phase I trial combining high-dose 90Y-labeled humanized anti-CEA monoclonal antibody with doxorubicin and peripheral blood stem cell rescue in advanced medullary thyroid cancer.. PubMed. 46(4). 620–33. 39 indexed citations

Sharkey, Robert M., A. J. Brenner, J. D. Burton, et al.. (2003). Radioimmunotherapy of non-Hodgkin's lymphoma with 90Y-DOTA humanized anti-CD22 IgG (90Y-Epratuzumab): do tumor targeting and dosimetry predict therapeutic response?. PubMed. 44(12). 2000–18. 65 indexed citations

Siegel, Jeffry A., David M. Goldenberg, Michael G. Stabin, et al.. (2003). Red marrow radiation dose adjustment using plasma FLT3-L cytokine levels: improved correlations between hematologic toxicity and bone marrow dose for radioimmunotherapy patients.. PubMed. 44(1). 67–76. 46 indexed citations

10.

Hajjar, George, Robert M. Sharkey, J. D. Burton, et al.. (2002). Phase I Radioimmunotherapy Trial with Iodine-131—Labeled Humanized MN-14 Anti—Carcinoembryonic Antigen Monoclonal Antibody in Patients with Metastatic Gastrointestinal and Colorectal Cancer. Clinical Colorectal Cancer. 2(1). 31–42. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact